U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369076) titled 'A Clinical Trial to Evaluate NB-4746 in Participants With Amyotrophic Lateral Sclerosis.' on Jan. 21.
Brief Summary: The purpose of this trial is to learn about the effects of NB-4746 compared with placebo in people with amyotrophic lateral sclerosis.
The questions this trial aims to answer in comparing NB-4746 to placebo are:
* What adverse events associated with taking NB-4746 are reported during this trial? (An adverse event is any sign or symptom that participants have during a trial. Adverse events may or may not be caused by treatments in the trial.)
* How does NB-4746 move into, through, and out of the body of the particip...